The efficacy of duloxetine for neuropathic pain a comparison of pregabalin

The efficacy of duloxetine for neuropathic pain a comparison of pregabalin - The efficacy of duloxetine for neuropathic pain a comparison of pregabalin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028475

Enrollment

Registered

2017-08-01

Start date

2017-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropathic pain

Interventions

duloxetine administration pregabalin administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: neuropathic pain caused by failed back surgery syndrome or lumbar canal stenosis

Exclusion criteria

Exclusion criteria: can not be self-assessment of pain

Design outcomes

Primary

Measure	Time frame
Visual analogue scale (VAS) is assessed before, and, 1 week, 2 weeks, 1 month, 2 months, 3 months after drug administration	—

Countries

Japan

Contacts

Public ContactHiromi Fujiii

Kajiki Hospital Anesthesiology

hiromif@ktd.biglobe.ne.jp086-293-3355

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026